Medway trust adds cervical cancer diagnostic tool to colposcopy services

Medway NHS Foundation Trust has adopted the ZedScan diagnostic medical device to improve the diagnosis of cervical cancer and pre-cancer in women referred to its colposcopy clinics at Medway Maritime Hospital in Kent. Using electrical impedance spectroscopy technology, ZedScan is used to detect cervical abnormalities before they develop into cancer.

Lead clinician for the colposcopy unit consultant obstetrician and gynaecologist Sharon Griffin said: “Within colposcopy, it is essential that we are able to confidently diagnose cervical abnormalities and make the best decision for patients at their first visit. The introduction of ZedScan to our services helps us to do this, and to get fuller and more accurate diagnosis for our patients. ZedScan also gives us the ability to confidently rule out disease in many cases and removes the need for a diagnostic biopsy and unnecessary follow-up appointments. This gives our patients peace of mind and helps us to see more patients more quickly by releasing appointment capacity.”

Following a service evaluation of more than 200 patients the Medway trust found that ZedScan, produced by Zilico, increased the detection of high grade disease by 26 per cent.

Picture: ZedScan is used as part of colposcopy procedures.

Published on page 12 of the August 2022 issue of RAD Magazine.